“…However, a portion of the leucine uptake is likely used in metabolic pathways related to up-and down-regulation of neurotransmitters and their receptors, which undergo significant bilateral changes after hearing loss (e.g., Potashner et al, 1997Potashner et al, , 2000Suneja et al, 1998aSuneja et al, ,b, 2000, as well as the expression of proteins, such as calcium binding proteins (e.g., Caicedo et al, 1997;Förster and Illing, 2000), GAP-43 (Michler and Illing, 2002;Kraus and Illing, 2004) and synaptophysin (e.g., Benson et al, 1997) which are also up-and down-regulated following hearing loss. Jin and Godfrey (2006) found that CA affects muscarinic acetylcholine receptor binding in the AVCN bilaterally, where binding increases steadily from 7 days to 2 months post ablation, with a 42% increase in the contralateral AVCN. This suggests the possibility of significant modulation of activity within neurons of AVCN via intracellular G-proteins.…”